You are here

  • Home
  • Archive
  • Volume 25, Issue 5
  • Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer: Does Histotype and Stage Matter?

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer: Does Histotype and Stage Matter?

Authors

  • Genevieve K. Lennox Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Lua R. Eiriksson Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Clare J. Reade Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Felix Leung Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Golnessa Mojtahedi Princess Margaret Hospital/University Health Network, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Eshetu G. Atenafu Biostatistics Department, Princess Margaret Hospital, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Sarah E. Ferguson Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada;Princess Margaret Hospital/University Health Network, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Joan Murphy Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology andPrincess Margaret Hospital/University Health Network, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  • Eleftherios P. Diamandis Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; andDepartment of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada. PubMed articlesGoogle scholar articles
  • Vathany Kulasingam Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada. PubMed articlesGoogle scholar articles
  • Marcus Q. Bernardini Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology andPrincess Margaret Hospital/University Health Network, Toronto, Ontario, Canada; PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Marcus Q. Bernardini, MD, MSc, FRCSC, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toronto, M700-610, University Avenue, Ontario, Canada M5G 2M9. E-mail: marcus.bernardini@uhn.ca.

Citation

Lennox GK, Eiriksson LR, Reade CJ, et al
Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer: Does Histotype and Stage Matter?
International Journal of Gynecologic Cancer 2015;25:809-814.

Publication history

  • Received November 24, 2014
  • First published June 1, 2015.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2015 by IGCS and ESGO